Search Browse Earnings

Lite Strategy, Inc.

Nasdaq:LITS

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Lite Strategy, Inc. — SlamSEC

Revenue

$65.3M

+33.8% YoY

FY 2025

Adj. EBITDA

$14.9M

22.9% margin

FY 2025

Net Income

-$32.0M

-49.0% margin

FY 2025

EPS (Diluted)

$2.67

FY 2025

Stock Price

$1.17

-2.5%

2026-03-10

52W Range

$0.95 – $9.00

P/E Ratio

0.4x

Market Cap

$42.5M

Cash

$3.7M

FY 2025

Total Debt

—

Net Cash

$3.7M

FY 2025

Enterprise Value

$38.8M

Debt / EBITDA

-0.2x

FY 2025

EV / EBITDA

2.6x

Employees

—